Sonoma Pharmaceuticals Inc (SNOA) — Financial Flexibility Index
Sonoma Pharmaceuticals Inc (SNOA) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-717.00K (operating CF $-764.00K minus capex $47.00K) represents 0% of total liabilities ($10.19 Million). Also explore Sonoma Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sonoma Pharmaceuticals Inc Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Sonoma Pharmaceuticals Inc across 21 annual periods. Check Sonoma Pharmaceuticals Inc (SNOA) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sonoma Pharmaceuticals Inc (2005–2025)
Year-by-year free cash flow to debt coverage for Sonoma Pharmaceuticals Inc. For the full company profile including market capitalisation, see Sonoma Pharmaceuticals Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $-8.00K | $-88.00K | $9.28 Million | ▲ +99.7% |
| 2024 | -0.28x | $-2.38 Million | $-2.40 Million | $8.60 Million | ▲ +61.2% |
| 2023 | -0.71x | $-5.88 Million | $-6.15 Million | $8.25 Million | ▼ -75.9% |
| 2022 | -0.41x | $-4.11 Million | $-4.25 Million | $10.15 Million | ▼ -21.9% |
| 2021 | -0.33x | $-3.20 Million | $-3.38 Million | $9.62 Million | ▲ +32.3% |
| 2020 | -0.49x | $-4.38 Million | $-4.59 Million | $8.94 Million | ▲ +83.3% |
| 2019 | -2.93x | $-11.62 Million | $-11.72 Million | $3.96 Million | ▲ +7.1% |
| 2018 | -3.16x | $-12.25 Million | $-12.44 Million | $3.88 Million | ▼ -63.6% |
| 2017 | -1.93x | $-7.77 Million | $-8.17 Million | $4.03 Million | ▲ +15.9% |
| 2016 | -2.29x | $-8.40 Million | $-8.75 Million | $3.66 Million | ▼ -4.8% |
| 2015 | -2.19x | $-6.55 Million | $-6.69 Million | $2.99 Million | ▼ -335.7% |
| 2014 | -0.50x | $-4.39 Million | $-4.89 Million | $8.73 Million | ▼ -403.0% |
| 2013 | 0.17x | $1.41 Million | $1.15 Million | $8.48 Million | ▲ +139.1% |
| 2012 | -0.42x | $-3.70 Million | $-4.03 Million | $8.71 Million | ▲ +30.5% |
| 2011 | -0.61x | $-4.25 Million | $-4.43 Million | $6.96 Million | ▲ +70.2% |
| 2010 | -2.05x | $-6.50 Million | $-6.64 Million | $3.17 Million | ▲ +60.4% |
| 2009 | -5.17x | $-16.44 Million | $-16.83 Million | $3.18 Million | ▼ -151.6% |
| 2008 | -2.06x | $-16.83 Million | $-17.45 Million | $8.18 Million | ▼ -44.0% |
| 2007 | -1.43x | $-17.21 Million | $-18.08 Million | $12.05 Million | ▲ +61.9% |
| 2006 | -3.75x | $-20.05 Million | $-20.52 Million | $5.35 Million | ▼ -42.1% |
| 2005 | -2.64x | $-12.49 Million | $-13.53 Million | $4.74 Million | — |